Delta-selective opioid peptides containing a single aromatic residue in the message domain: an NMR conformational analysis. 1996

O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
Dipartimento di Chimica, Università di Napoli Federico II, Italy.

The sequence of deltorphin I, a delta-selective opioid agonist, has been systematically modified by inserting conformationally constrained C alpha, alpha disubstituted apolar residues in the third position. As expected, substitution of Phe with Ac6c, Ac5c and Ac3c yields analogues with decreasing but sizeable affinity. Surprisingly, substitution with Aib yields an analogue with almost the same binding affinity of the parent compound but with a greatly increased selectivity. This is the first case of a potent and very selective opioid peptide containing a single aromatic residue in the message domain, that is, only Tyr1. Here we report a detailed conformational analysis of [Aib3]deltorphin I and [Ac6c3]deltorphin I in DMSO at room temperature and in a DMSO/water cryomixture at low temperature, based on NMR spectroscopy and energy calculations. The peptides are highly structured in both solvents, as indicated by the exceptional finding of a nearly zero temperature coefficient of Val5 NH resonance. NMR data cannot be explained on the basis of a single structure but it was possible to interpret all NMR data on the basis of a few structural families. The conformational averaging was analysed by means of an original computer program that yields qualitative and quantitative composition of the mixture. Comparison of the preferred solution conformation with two rigid delta-selective agonists shows that the shapes of [Aib3]deltorphin I and [Ac6c3]deltorphin I are consistent with those of rigid agonists and that the message domain of opioid peptides can be defined only in conformational terms.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic

Related Publications

O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
January 1986, NIDA research monograph,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
March 1989, Journal of medicinal chemistry,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
July 1991, Biopolymers,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
January 2021, Current medicinal chemistry,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
August 2011, The journal of physical chemistry. B,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
March 2021, Journal of medicinal chemistry,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
November 1993, The Journal of biological chemistry,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
August 1994, European journal of biochemistry,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
January 1986, NIDA research monograph,
O Crescenzi, and P Amodeo, and G Cavicchioni, and R Guerrini, and D Picone, and S Salvadori, and T Tancredi, and P A Temussi
February 2013, Organic & biomolecular chemistry,
Copied contents to your clipboard!